Solomon DH, Pincus T, Shadick NA, Stratton J, Ellrodt J, Santacroce L, Katz JN, Smolen JS, Chatpar PC, Stocks M, Mundell B, Downey C, Gebre MA, Torralba KD, White DW, Baudek MM, Szlembarski SJ, Barnhart SI, Bilal J, Lee D, Redford A, Buchfuhrer J, Kramer HR, Kwoh CK, Villatoro‐Villar M, Patnaik A, Guzman E, Trachtman RA, Tesser J, Music D, Mickey L, Amin M, Simpson J, Staniszewski K, Potter J, Sundhar J, Sheingold J, Schmukler J, Horowitz DL, Gulko HE, Kong‐Rosario M, Quinet RJ, Dhulipala S, Patel R, Keshavamurthy C, Bedoya GC, Dunn R, Kumar B, Lenert A, Zembrzuska H, Lenert P, Anandarajah AP, Yang AH, Grinnell‐Merrick L, Goldsmith S, Zelie J, Wise LM, Zagelbaum Ward NK, Kaine J. Implementing Treat to Target (TTT) for Rheumatoid Arthritis (RA) During COVID: Results of a Virtual Learning Collaborative (LC) Program.
Arthritis Care Res (Hoboken) 2021;
74:572-578. [PMID:
35119779 PMCID:
PMC9011823 DOI:
10.1002/acr.24830]
[Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/26/2021] [Revised: 11/23/2021] [Accepted: 12/02/2021] [Indexed: 11/23/2022]
Abstract
Objective
A treat‐to‐target (TTT) approach improves outcomes in rheumatoid arthritis (RA). In prior work, we found that a learning collaborative (LC) program improved implementation of TTT. We conducted a shorter virtual LC to assess the feasibility and effectiveness of this model for quality improvement and to assess TTT during virtual visits.
Methods
We tested a 6‐month virtual LC in ambulatory care. The LC was conducted during the 2020–2021 COVID‐19 pandemic when many patient visits were conducted virtually. All LC meetings used videoconferencing and a website to share data. The LC comprised a 6‐hour kickoff session and 6 monthly webinars. The LC discussed TTT in RA, its rationale, and rapid cycle improvement as a method for implementing TTT. Practices provided de‐identified patient visit data. Monthly webinars reinforced topics and demonstrated data on TTT adherence. This was measured as the percentage of TTT processes completed. We compared TTT adherence between in‐person visits versus virtual visits.
Results
Eighteen sites participated in the LC, representing 45 rheumatology clinicians. Sites inputted data on 1,826 patient visits, 78% of which were conducted in‐person and 22% of which were held in a virtual setting. Adherence with TTT improved from a mean of 51% at baseline to 84% at month 6 (P for trend < 0.001). Each aspect of TTT also improved. Adherence with TTT during virtual visits was lower (65%) than during in‐person visits (79%) (P < 0.0001).
Conclusion
Implementation of TTT for RA can be improved through a relatively low‐cost virtual LC. This improvement in TTT implementation was observed despite the COVID‐19 pandemic, but we did observe differences in TTT adherence between in‐person visits and virtual visits.
Collapse